West Pharmaceutical Services, Inc. (NYSE:WST – Get Rating) declared a quarterly dividend on Thursday, April 27th, Zacks reports. Shareholders of record on Wednesday, July 26th will be given a dividend of 0.19 per share by the medical instruments supplier on Wednesday, August 2nd. This represents a $0.76 dividend on an annualized basis and a yield […]
West Pharmaceutical Services (NYSE:WST – Get Rating) issued its quarterly earnings data on Thursday. The medical instruments supplier reported $1.98 earnings per share for the quarter, topping analysts’ consensus estimates of $1.67 by $0.31, Briefing.com reports. The business had revenue of $716.60 million during the quarter, compared to the consensus estimate of $697.28 million. West […]
West Pharmaceutical Services (NYSE:WST – Get Rating) updated its FY23 earnings guidance on Thursday. The company provided EPS guidance of $7.50-7.65 for the period, compared to the consensus EPS estimate of $7.50. The company issued revenue guidance of $2.965-2.990 billion, compared to the consensus revenue estimate of $2.96 billion. Analyst Upgrades and Downgrades A number […]
Raymond James Trust N.A. cut its stake in shares of West Pharmaceutical Services, Inc. (NYSE:WST – Get Rating) by 20.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,260 shares of the medical instruments supplier’s stock after selling […]
Profund Advisors LLC raised its stake in shares of West Pharmaceutical Services, Inc. (NYSE:WST – Get Rating) by 3.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 8,787 shares of the medical instruments supplier’s stock after buying an additional 261 shares […]